Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 260 of 1,261
  1. US 11352365

    Biased potent opioid-like agonists as improved medications to treat chronic and acute pain and methods of using the same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  2. US 11352417

    Method of treating an allergy with allergen-specific monoclonal antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  3. US 11352389

    Treatment of haematological malignancies

    Academisch Ziekenhuis Leiden h.o.d.n. Leids Universitair Medisch Centrum · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  4. US 11351153

    Antimicrobial compositions containing a synergistic combination of activated creatinine and an imidazole antifungal agent

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  5. US 11351256

    Room temperature stable lyophilized protein

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  6. US 11351264

    PAR2 mimetic peptides and uses thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  7. US 11352428

    Modulation of immune response using BTLA agonist antibodies

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  8. US 11352447

    Gellan gum hydrogels, preparation, methods and uses thereof

    STEMMATTERS, BIOTECNOLOGIA E MEDICINA REGENERATIVA, S.A. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  9. US 11352435

    Anti-CD133 monoclonal antibodies and related compositions and methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  10. US 11352426

    CD3 binding polypeptides

    Aptevo Research and Development LLC · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  11. US 11353463

    Redox-based reagents for methionine bioconjugation

    The Regents of the University of California · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  12. US 11352410

    Anti-KK-LC-1 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  13. US 11352403

    Activatable interleukin-2 polypeptides and methods of use thereof

    Werewolf Therapeutics, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  14. US 11352402

    Interleukin-4 receptor-binding fusion proteins and uses thereof

    Medicenna Therapeutics Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  15. US 11352395

    Anticancer peptides

    IDP DISCOVERY PHARMA, S.L. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  16. US 11352331

    Crystal and salt of 4-(naphthalen-1-yl)-4H-1,2,4-triazole compound and preparation method therefor

    Medshine Discovery Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  17. US 11352356

    Inhibitors of plasma kallikrein and uses thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  18. US 11352350

    IRAK degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  19. US 11352316

    Opioid receptor modulators and products and methods related thereto

    EPIODYNE, INC. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  20. US 11351276

    Radiopharmaceutical compositions of radioactive halogenated benzylguanidine

    Jubilant Draximage Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  21. US 11351266

    Conjugate of isotretinoin and peptide

    CAREGEN CO., LTD. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  22. US 11351199

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  23. US 11351231

    Lysosomal targeting peptides and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  24. US 11351205

    Microbiome related immunotherapies

    Finch Therapeutics Holdings LLC · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.